PartsTable
Technical Data Sheet
Download PDF

NDC00173-0449-02 — SUMATRIPTAN SUCCINATE INJECTION

✓ Government record, cited
— · COMPONENT
PRODUCT OVERVIEW

NDC00173-0449-02: SUMATRIPTAN SUCCINATE INJECTION.

SUMATRIPTAN SUCCINATE INJECTION. Key specifications include primary_container_type: VIAL, SINGLE DOSE, therapeutic_equivalent: TO IMITREX BY GLAXO, primary_container_content_quantity: 2.000 MILLILITERS, active_medicament_medicinal_strength: 6.000 MILLIGRAMS SUMATRIPTAN SUCCINATE PER 0.5 MILLILITERS, part_name_assigned_by_controlling_agency: SUMATRIPTAN SUCCINATE INJECTION 6MG/0.5ML 2ML VIAL 5S. This part is cataloged in the U.S.

Government catalog under NSN 6505-01-374-5874, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.

Verify compatibility with your specific system configuration before ordering.

WHERE IT FITS
NDC00173-0449-02
NSN: 6505-01-374-5874
FSC: 6505 — Drugs and Biologicals
CAGE: 34006 — GLAXO WELLCOME INC (USA)
SPECIFICATIONS
primary_container_typeVIAL, SINGLE DOSE
therapeutic_equivalentTO IMITREX BY GLAXO
total_primary_container_quantity5
primary_container_content_quantity2.000 MILLILITERS
active_medicament_medicinal_strength6.000 MILLIGRAMS SUMATRIPTAN SUCCINATE PER 0.5 MILLILITERS
part_name_assigned_by_controlling_agencySUMATRIPTAN SUCCINATE INJECTION 6MG/0.5ML 2ML VIAL 5S
NSN6505-01-374-5874
COMPONENT DIAGRAM
COMPONENT MAIN IC EDGE CONNECTOR No detailed specs available SUMATRIPTAN SUCCINATE INJECTION TITLE COMPONENT PN NDC00173-0449-02 MFR SUMATRIPTAN SUCCINATE
KEY FEATURES
•
THERAPEUTIC EQUIVALENT: TO IMITREX BY GLAXO
•
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 MILLILITERS
•
PRIMARY CONTAINER TYPE: VIAL, SINGLE DOSE
•
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 6.000 MILLIGRAMS SUMATRIPTAN SUCCINATE PER 0.5 MILLILITERS
•
TOTAL PRIMARY CONTAINER QUANTITY: 5
TECHNICAL CHARACTERISTICS
THERAPEUTIC EQUIVALENTTO IMITREX BY GLAXO
PRIMARY CONTAINER CONTENT QUANTITY2.000 MILLILITERS
PRIMARY CONTAINER TYPEVIAL, SINGLE DOSE
PART NAME ASSIGNED BY CONTROLLING AGENCYSUMATRIPTAN SUCCINATE INJECTION 6MG/0.5ML 2ML VIAL 5S
ACTIVE MEDICAMENT MEDICINAL STRENGTH6.000 MILLIGRAMS SUMATRIPTAN SUCCINATE PER 0.5 MILLILITERS
TOTAL PRIMARY CONTAINER QUANTITY5
OTHER ITEMS IN FSC 6505 — Drugs and Biologicals
Items in the same Federal Supply class. No interchangeability or substitution relationship is implied.
6505-00-000-0073 6505-00-000-0110 6505-00-000-0134 6505-00-000-0135 6505-00-001-3344 6505-00-001-3345 6505-00-001-3346 6505-00-001-3347
SUBSTITUTES & CROSS-REFERENCES 2
IMITREXReference document
Same NSN cross-reference
Reference document — Secondary reference
IMITREX INJECTIONReference document
Same NSN cross-reference
Reference document — Secondary reference
LIFECYCLE
NSN statusActive· U.S. Government catalog
Shelf-life managedNo demilitarization required
Ready to buy NDC00173-0449-02?
Compare prices from verified sellers on eBay
Buy on eBay →
As an eBay Partner, PartsTable may earn a commission. Your price is not affected.
FREQUENTLY ASKED QUESTIONS
What is NDC00173-0449-02?
NDC00173-0449-02 is a SUMATRIPTAN SUCCINATE INJECTION.
What parts can replace NDC00173-0449-02?
There are 2 known substitutes for NDC00173-0449-02: IMITREX, IMITREX INJECTION. Substitute compatibility should be verified for your specific system.
What is the NSN for NDC00173-0449-02?
NDC00173-0449-02 is cataloged in the U.S. Government catalog under NSN 6505-01-374-5874. This indicates validated use in U.S. government and defense supply chains.
Community Feedback
Leave a Comment
Comments are reviewed before appearing. You will receive an email to verify before your comment appears.

Request a Quote — NDC00173-0449-02